https://www.selleckchem.com/pr....oducts/Fedratinib-SA
039). Postoperative mobilization was commenced significantly earlier in the IBR group (mobilization on postoperative day 1 82.1 versus 68.7 percent; p 0.001), and concordantly the mean length of hospital stay was significantly shorter (7.3 (SD3.7) versus 8.9 (SD13. days; p 0.001). IBR is feasible and cannot be considered a risk factor for complications or flap outcome. Our results support the current trend towards an increasing number of IBR. Especially in times of economic pressure in health care, the